Arsani William sold $3.0M of DSGN
director at Design Therapeutics, Inc.. 562,627 shares at an average of $5.25, traded Aug 13, 2025, filed Aug 14, 2025.
Score components
- +15RoleDirector
- +25Trade size$3.0M at market
- +5Share of holdings soldSold 19% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-25-021842, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 13, 2025 | SOpen-market sale Common Stockindirect: By Logos Global Master Fund LP | -345,000 | $5.25 | $1.8M | 2,655,000 | Aug 14, 2025 |
| Aug 13, 2025 | SOpen-market sale Common Stockindirect: By Logos Opportunities Fund II LP | -217,627 | $5.25 | $1.1M | 1,000,000 | Aug 14, 2025 |
Related signals
Other insiders at Design Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 20Weak | DSGNsell Design Therapeutics, Inc. | Deepa Prasad director | $24k 3,806 shares | -16% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.